🤖 Search 5,000+ AI tools Ask our bot for help →

Discover the latest tools and trends in AI 🔮

Join 60,000+ subscribers including Amazon, Apple, Google, and Microsoft employees reading our free newsletter.

[email protected] Subscribe

Saguaro Biosciences secures $3M seed funding

Saguaro Biosciences secures $3M seed funding
Saguaro Biosciences secures $3M seed funding

Saguaro Biosciences, based in Quebec City, raised $3M in Seed funding for their live cell reagents.

The round was led by AQC Capital and Anges Québec, with notable participation from Martin Leblanc of CellCarta Biosciences, Investissement Quebec, and Ville de Québec.

Plans for the funds include the commercial expansion of ChromaLive™, their AI-enhanced reagent platform for cellular imaging and analysis.

CEO Louis Turcotte stated, "This funding will accelerate our technology's adoption and expand our portfolio, contributing to transformative applications in human health."

Saguaro Biosciences' ChromaLive™ is gaining traction with major pharmaceutical companies, positioning it as an innovator in AI-enabled cell analysis.

Comments